New and updated preclinical and clinical data presented by biopharma firms at the American Association for Cancer Research annual meeting, including: Editas, Elpis, Essa, Gennao, Genocea, Gracell, Hotspot, Imcheck, Immunomic, IMV, Imvax, Inmune, Innocare, Innovent, Inventisbio, IO, Ionctura, Iterion, Iteos, Jazz, Kronos, Oncoone, Oncorus, Orphagen, Orum, Palleon, Pharmabcine, Phio, PIC, Primmune, Pyxis, Qihan, Redx, Rhizen, Scorpion, Seagen, Second Genome, Seneca, Senti, Shattuck, SQZ, Surface Oncology, Sutro, Syros, Tachyon, Theseus, Transgene, Triumvira, Umoja, Vincerx, Vivace, Xencor, Yiviva, Zentalis.